Table 1 Patient characteristics
Control | BCPAP | p-value | |
|---|---|---|---|
N | 66 | 108 | |
Duration of the study | 1 year | 2 years | |
Age in yrs, mean, ± SD | 72 ± 11 | 72 ± 11 | - |
Male, n (%) | 46 (70) | 69 (64) | - |
Medication, n (%) | |||
Loop-diuretics | 56 (85) | 97 (90) | - |
Opioids | 34 (51) | 47 (44) | - |
Nitroglycerine | 29 (44) | 39 (36) | - |
Admission CCU, n (%) | 35 (53) | 84 (78) | < 0.01 |
Admission ICU, n (%) | 31 (47) | 24 (22) | < 0.01 |
CCU stay in days, median (IQR) | 3 (2–5) | 2 (2–3) | - |
CCU stay in days, mean (SD) | 2.0 (2.3) | 2.3 (2.7) | - |
ICU stay in days, median (IQR) | 2 (2–5) | 4 (2–7) | < 0.01 |
ICU stay in days, mean (SD) | 2.0 (3.5) | 1.3 (3.4) | - |
Hospital stay in days, median (IQR) | 16 (8–24) | 8 (2–16) | < 0.01 |
Hospital stay in days, mean (SD) | 20.2 (23.5) | 13.9 (17.9) | 0.047 |
Hospital survivors, n of total (%) | 50 (76) | 84 (78) | - |
6 month survival, n of total (%) | 49 (74) | 81 (75) | - |